Laura Crecelius, MD
Obstetrics & Gynecology · Corinth, MSNPI 1861470627
Payments from drug & device makers
Across 106 payments — averaging $17.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$258
- Novo Nordisk$246
- AstraZeneca$179
- Bayer$134
- Astellas Pharma US Inc$132
- Lilly USA, LLC$124
- plus $825 from 16 others
What the payments were for
- Food & beverage$1,897100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 15 | $258 |
| Novo Nordisk | 17 | $246 |
| AstraZeneca | 10 | $179 |
| Bayer | 7 | $134 |
| Astellas Pharma US Inc | 5 | $132 |
| Lilly USA, LLC | 8 | $124 |
| AbbVie | 8 | $119 |
| Merck | 2 | $108 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $105 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $92 |
| Pfizer | 5 | $83 |
| Exact Sciences | 3 | $46 |
| Hologic Sales And Service, LLC | 1 | $42 |
| Phathom Pharmaceuticals, Inc. | 3 | $42 |
| Mylan Specialty L.p. | 2 | $36 |
| Pharmacosmos Therapeutics Inc. | 2 | $34 |
| Radius Health, Inc. | 1 | $30 |
| Biohaven Pharmaceuticals, Inc. | 2 | $28 |
| Mckesson Medical-surgical, Inc. | 1 | $20 |
| Amgen | 1 | $14 |
| Sumitomo Pharma America, Inc. | 1 | $13 |
| GSK | 1 | $12 |
How this compares
$1,897 in reported general payments places this provider in the 65th percentile of 318 obstetrics & gynecology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 75 | $2,471 |
| Estradiol (Once Weekly)Estradiol | 13 | $741 |
| Betamethasone Valerate | 15 | $443 |
| Oxybutynin Chloride ErOxybutynin Chloride | 22 | $397 |
| NitrofurantoinNitrofurantoin Macrocrystal | 19 | $294 |
| Ibandronate Sodium | 12 | $163 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 13 | $157 |
| Fluconazole | 18 | $62 |
| Citalopram HbrCitalopram Hydrobromide | 13 | $62 |
| Paroxetine Hcl | 12 | $41 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Corinth
- Quinisha LoganCorinth$3K
- Michael LivingstonFlowood$2.9M
- Noel DuplantierBay Saint Louis$273K
- Robert DesantisEllisville$212K
- Lori FultonJackson$102K
- Sheila BouldinJackson$74K
- Melissa BarnettTupelo$50K
- Ahmet BedestaniFlowood$41K
- Sarah NovotnyJackson$41K
- Stacey KreherBay St. Louis$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.